150 related articles for article (PubMed ID: 24719472)
1. Interaction of fibronectin with semen amyloids synergistically enhances HIV infection.
Roan NR; Chu S; Liu H; Neidleman J; Witkowska HE; Greene WC
J Infect Dis; 2014 Oct; 210(7):1062-6. PubMed ID: 24719472
[TBL] [Abstract][Full Text] [Related]
2. Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.
Roan NR; Liu H; Usmani SM; Neidleman J; Müller JA; Avila-Herrera A; Gawanbacht A; Zirafi O; Chu S; Dong M; Kumar ST; Smith JF; Pollard KS; Fändrich M; Kirchhoff F; Münch J; Witkowska HE; Greene WC
J Virol; 2014 Jul; 88(13):7221-34. PubMed ID: 24741080
[TBL] [Abstract][Full Text] [Related]
3. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.
Roan NR; Müller JA; Liu H; Chu S; Arnold F; Stürzel CM; Walther P; Dong M; Witkowska HE; Kirchhoff F; Münch J; Greene WC
Cell Host Microbe; 2011 Dec; 10(6):541-50. PubMed ID: 22177559
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of herpes simplex virus (HSV) infection by seminal plasma and semen amyloids implicates a new target for the prevention of HSV infection.
Torres L; Ortiz T; Tang Q
Viruses; 2015 Apr; 7(4):2057-73. PubMed ID: 25903833
[TBL] [Abstract][Full Text] [Related]
5. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection.
Capule CC; Brown C; Olsen JS; Dewhurst S; Yang J
J Am Chem Soc; 2012 Jan; 134(2):905-8. PubMed ID: 22239120
[TBL] [Abstract][Full Text] [Related]
6. Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture.
Tang Q; Roan NR; Yamamura Y
J Virol; 2013 Dec; 87(23):12583-91. PubMed ID: 24027327
[TBL] [Abstract][Full Text] [Related]
7. Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.
Sheik DA; Dewhurst S; Yang J
Acc Chem Res; 2017 Sep; 50(9):2159-2166. PubMed ID: 28809479
[TBL] [Abstract][Full Text] [Related]
8. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC
J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482
[TBL] [Abstract][Full Text] [Related]
9. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
[TBL] [Abstract][Full Text] [Related]
10. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J
Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles.
Sheik DA; Brooks L; Frantzen K; Dewhurst S; Yang J
ACS Nano; 2015 Feb; 9(2):1829-1836. PubMed ID: 25619867
[TBL] [Abstract][Full Text] [Related]
12. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.
Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S
J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717
[TBL] [Abstract][Full Text] [Related]
14. Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection.
LoRicco JG; Xu CS; Neidleman J; Bergkvist M; Greene WC; Roan NR; Makhatadze GI
J Biol Chem; 2016 Jul; 291(27):14045-14055. PubMed ID: 27226574
[TBL] [Abstract][Full Text] [Related]
15. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC
J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786
[TBL] [Abstract][Full Text] [Related]
16. A molecular tweezer antagonizes seminal amyloids and HIV infection.
Lump E; Castellano LM; Meier C; Seeliger J; Erwin N; Sperlich B; Stürzel CM; Usmani S; Hammond RM; von Einem J; Gerold G; Kreppel F; Bravo-Rodriguez K; Pietschmann T; Holmes VM; Palesch D; Zirafi O; Weissman D; Sowislok A; Wettig B; Heid C; Kirchhoff F; Weil T; Klärner FG; Schrader T; Bitan G; Sanchez-Garcia E; Winter R; Shorter J; Münch J
Elife; 2015 Aug; 4():. PubMed ID: 26284498
[TBL] [Abstract][Full Text] [Related]
17. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
Elias AK; Scanlon D; Musgrave IF; Carver JA
Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
[TBL] [Abstract][Full Text] [Related]
18. Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies.
von Maltitz P; Wettstein L; Weil T; Schommers P; Klein F; Münch J
J Virol; 2024 Apr; 98(4):e0119023. PubMed ID: 38501840
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.
Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ
J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984
[TBL] [Abstract][Full Text] [Related]
20. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.
Hauber I; Hohenberg H; Holstermann B; Hunstein W; Hauber J
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9033-8. PubMed ID: 19451623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
